New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha and Gamma variants following third dose booster with AstraZeneca COVID-19 Vaccine; Additional analysis showed increased antibody response to Omicron after a third dose.
Tag: astrazeneca
AstraZeneca’s COVID-19 vaccine significantly boosted antibody levels against Omicron
Neutralising antibody levels against Omicron following a third dose boost of AstraZeneca’s COVID-19 vaccine were broadly similar to levels achieved after two doses against the Delta variant
AstraZeneca COVID-19 Vaccine and mRNA COVID-19 vaccines showed similar and favorable safety profiles in a population-based cohort study of over a million people
Safety profiles of AstraZeneca’s COVID-19 Vaccine, and the mRNA-based vaccine were similar and overall favorable.